Daunorubicin

CAS: 20830-81-3

Ref. 3D-MD32002

Produktinformation

• Name: Daunorubicin
• Synonyme: (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-n aphthacenedioneDaunomycin
• Marke: Biosynth
• Beschreibung: Anthracycline antibiotic with potent anti-tumoral activity. The compound interferes with DNA replication and RNA transcription since it intercalates between the base pairs of nucleic acids. It also inhibits the topoisomerase II, proteasome and generates free radicals, which leads to cell death of treated cells. Moreover, daunorubicin triggers apoptosis trough the stimulation of ceramide synthesis. It has been used as chemotherapy agent for the treatment of myeloid leukaemia (AML) and acute lymphocytic leukaemia (ALL).

Chemische Eigenschaften

• Molekulargewicht: 527.52 g/mol
• Formel: C₂₇H₂₉NO₁₀
• Reinheit: Min. 95%